We are live on ! Find out more
CFO

CVA Family Office Portfolio holdings

AUM $1.1B
1-Year Est. Return 26.6%
This Fund
S&P 500
This Quarter Est. Return
+14.4%
1 Year Est. Return
+26.6%
3 Year Est. Return
+71.56%
5 Year Est. Return
+71.4%
10 Year Est. Return
AUM
$1.1B
AUM Growth
+$155M
Cap. Flow
+$42.1M
Cap. Flow %
3.81%
Top 10 Hldgs %
37.97%
Holding
1,894
New
56
Increased
839
Reduced
527
Closed
92

Sector Composition

Rank Sector Weight
1 Miscellaneous 75.76%
2 Technology 8.44%
3 Financials 3.67%
4 Industrials 2.22%
5 Communication Services 2.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VWO icon
151
Vanguard FTSE Emerging Markets ETF
VWO
$128B
$789K 0.07%
13,222
+4,180
+46% +$246K
MDT icon
152
Medtronic
MDT
$120B
$789K 0.07%
10,083
-741
-7% -$59.8K
MGK icon
153
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.7B
$781K 0.07%
8,890
-230
-3% -$19.6K
MRVL icon
154
Marvell Technology
MRVL
$201B
$779K 0.07%
2,616
+22
+0.8% +$4.41K
SCHO icon
155
Schwab Short-Term US Treasury ETF
SCHO
$14.1B
$773K 0.07%
32,027
+14
+0% +$338
BAC icon
156
Bank of America
BAC
$438B
$765K 0.07%
13,418
+349
+3% +$18.6K
SCHW
157
Charles Schwab
SCHW
$189B
$758K 0.07%
8,211
-133
-2% -$12.1K
COP icon
158
ConocoPhillips
COP
$161B
$751K 0.07%
7,221
+1,532
+27% +$182K
IBDY icon
159
iShares iBonds Dec 2033 Term Corporate ETF
IBDY
$1.16B
$750K 0.07%
29,142
VIGI icon
160
Vanguard International Dividend Appreciation ETF
VIGI
$9.29B
$750K 0.07%
8,031
+15
+0.2% +$1.39K
MMM icon
161
3M
MMM
$86.9B
$746K 0.07%
4,607
+121
+3% +$18.3K
MO icon
162
Altria Group
MO
$115B
$743K 0.07%
10,327
+69
+0.7% +$4.82K
TMO icon
163
Thermo Fisher Scientific
TMO
$227B
$740K 0.07%
1,475
-89
-6% -$42.7K
VTEB icon
164
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.1B
$739K 0.07%
14,608
-1,554
-10% -$78.1K
FNB icon
165
FNB Corp
FNB
$6.65B
$726K 0.07%
38,058
+65
+0.2% +$1.16K
CRH icon
166
CRH
CRH
$62.7B
$697K 0.06%
6,513
+26
+0.4% +$2.86K
DUK icon
167
Duke Energy
DUK
$93.7B
$693K 0.06%
5,477
+8
+0.1% +$1.01K
ICSH icon
168
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.56B
$682K 0.06%
13,486
GLD icon
169
SPDR Gold Trust
GLD
$149B
$673K 0.06%
1,826
GSEW icon
170
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$2.04B
$669K 0.06%
7,088
+1
+0% +$91
IYW icon
171
iShares US Technology ETF
IYW
$25.5B
$665K 0.06%
2,635
VEU icon
172
Vanguard FTSE All-World ex-US ETF
VEU
$71.2B
$663K 0.06%
7,918
+36
+0.5% +$2.94K
STX icon
173
Seagate
STX
$192B
$658K 0.06%
682
+97
+17% +$74K
NEAR icon
174
iShares Short Maturity Bond ETF
NEAR
$5.05B
$657K 0.06%
12,972
EIPX icon
175
FT Energy Income Partners Strategy ETF
EIPX
$587M
$651K 0.06%
20,796
+158
+0.8% +$5.05K

Similar funds

CVA Family Office's Q2 2026 Portfolio in Review

As of Q2 2026, CVA Family Office held 1,894 positions worth $1.1B, up 16% from $950M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

CVA Family Office deployed $42.1M of net new capital in Q2 2026, opening 56 new positions and adding to 839 existing holdings. Its largest new stake was Janus Henderson AAA CLO ETF: 19,448 shares worth $982K.

By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, up from 75% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Health Care ETF, an estimated $1.11M trimmed.

  • CVA Family Office's largest Q2 2026 buy was Janus Henderson AAA CLO ETF: 19,448 shares worth $982K.
  • CVA Family Office added most to Vanguard Morningstar Total Stock Market ETF in Q2 2026, an estimated $7.16M increase.
  • CVA Family Office's biggest Q2 2026 reduction was Vanguard Health Care ETF, cutting an estimated $1.11M.
  • CVA Family Office fully exited iShares 20+ Year Treasury Bond ETF in Q2 2026, selling an estimated $40.9K.
  • CVA Family Office's ten largest holdings make up 38% of its $1.1B portfolio in Q2 2026.
  • CVA Family Office opened 56 new positions and closed 92 in Q2 2026.
  • CVA Family Office's portfolio value rose 16% quarter-over-quarter to $1.1B.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.